pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 9·1 min read
save

UK commission proposes new framework to regulate AI-driven medical tools

Sep 9, 2026·read at STAT ↗RegulatoryNeutral

A UK commission released a report on Thursday outlining 44 recommendations for how artificial intelligence should be governed in the medical sector.

The guidance aims to capture AI's promise, such as automating the review of millions of diagnostic scans for diabetic eye disease, while putting safeguards in place to protect patients and ensure equitable access.

Key proposals include a staged approval process for new AI models and a reporting system that requires clinicians to log performance issues or malfunctions as the algorithms evolve.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: U.K. unveils recommendations for regulating AI in medicine”

read at STAT ↗
489 words · retrieved Sep 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTRAZENECA
topics
Ophthalmology2ApprovalCOPDCardiologyHeart FailureType 2 Diabetes

related stories

  • Sep 15STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseasesSTAT
  • Sep 10Oz says ‘AI-based avatars’ can help rural communities. Some leaders disagreeSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech
  • Sep 21Novo’s plan to hit $23B in revenue by 2035 leaves investors wantingBioSpace